Arsenic and nicotine co-exposure lead to some synergistic effects on oxidative stress and apoptotic markers in young rat blood, liver, kidneys and brain  by Jain, Anshu et al.
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Arsenic  and  nicotine  exposure  has  been  a major  health  concern  globally.  Individually  both  these  tox-
icants  increase  the risk  to various  diseases  including  cancers.  However,  limited  information  exists  on
the  co-exposure.  In  this  study,  we  evaluate  the  effects  of their  individual  and  combined  exposure  and  if
co-exposure  to these  toxicants  might  have  a synergism  or  antagonism.  Male  rats  were  exposed  to a  very
low  dose  of  arsenic  (25  ppm  in  drinking  water)  or  nicotine  (0.25  mg/kg,  sub-cutaneously)  for  a  period  of
5 months  and  post  exposure  various  biochemical  variables  indicative  of oxidative  stress  and  apoptosis
evaluated.  Almost  all glutathione  linked  enzymes  showed  marked  alteration  in  individual  as  well  as  co-
exposure treated  groups.  While  serum  creatinine  and  apoptosis  indicator,  lactate  dehydrogenase  (LDH)
were signiﬁcantly  increased  in  both  treatments,  an additive  effect  was  noted  in co-exposure  group.  A sim-
ilar trend  was  also  seen  in brain  and  liver  but  not  in  kidneys.  Gene  expression  studies  showed  marked
reduction  in  catalase,  Cu-Zn  SOD, GST,  there  was  a signiﬁcant  up  regulation  in  Bax,  caspase  3 in various  tis-ynergism sues  along  with  urinary  8-OHdG  levels,  indicative  of  DNA  damage  and  apoptosis.  Interestingly,  a decrease
in  liver  arsenic  concentration  was  noted in  co-exposed  group  compared  to  arsenic  alone  exposed  group.
In conclusion,  the  present  study  suggests  that  arsenic  and  nicotine  exhibited  signiﬁcant  toxicity  during
individual  exposure  whereas  co-exposure  to these  toxins  showed  variable  conditions  (indicative  of  both
m)  in
rs.  Pusynergism  and  antagonis
©  2015  The  Autho
. Introduction
Arsenic is predominately present in water, soil, and air from
atural and anthropogenic sources, however drinking of contam-
nated drinking water is the main cause of acute and chronic
dverse health effects in humans [12,21]. Over 200 million peo-
le worldwide are at risk, out of which more than 100 million are
esiding in West Bengal, India ([43] and Bangladesh); areas where
roundwater arsenic concentrations exceed the World Health
rganization maximum permissible level of 50 mg/L [60]. More-
ver, many states of United States too have reported signiﬁcant
rsenic groundwater concentrations (up to 50 ppm) [63,30]. Epi-
emiological studies have suggested a strong correlation between
hronic arsenic exposure and various human diseases such as
yperkeratosis, atherosclerosis, diabetes, obstructive pulmonary
iseases [12,64,63,44]. Long term arsenic exposure has also been
∗ Corresponding author. Fax: +91 751 2341148.
E-mail addresses: sjsﬂora@hotmail.com, sjsﬂora@drde.drdo.in,
jsﬂora@gmail.com (S.J.S. Flora).
ttp://dx.doi.org/10.1016/j.toxrep.2015.09.003
214-7500/© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access
c-nd/4.0/). male rats.
blished  by Elsevier  Ireland  Ltd.  This  is an  open  access  article  under  the CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
linked to cancer of skin, lung, colon and rectal [70,22,29]. While
the mechanism of arsenic induced toxicity is not clearly deﬁned,
several mechanisms have been proposed of which arsenic-induced
oxidative stress is among most widely accepted and studied [12].
Nicotine, the most important constituent of tobacco, is respon-
sible for habit forming properties of tobacco chewing and cigarette
smoking. Nicotine poisoning produces nausea, vomiting, abdomi-
nal pain, diarrhoea, headaches, sweating, and pallor however, more
severe poisoning results in dizziness, weakness, and confusion, pro-
gressing to convulsions, hypotension, and coma [28]. Like arsenic,
Nicotine also induces oxidative stress which ultimately results in
several pathological conditions that needs further assessment.
Although arsenic and nicotine have been studied individ-
ually many times, there are only a few co-exposure studies.
We recently demonstrated that pre-exposure to nicotine before
arsenic exposure revealed interesting toxicokinetic and oxida-
tive stress modulating interactions in the brain and liver of rats
[47]. Co-exposure studies have reported synergism between both
compounds [17], impaired arsenic methylation and metabolism
[19,34,33], increase risk of lung cancer [4,9] and oxidative stress
[12,24]. Due to ever increasing exposure to these environmental
 article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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oxicants particularly in developing countries, there is increased
nterest to investigate the role of these toxicants individually and
lso interactive if co-exposure takes place [5]. In the present study
e studied the individual and combined exposure to arsenic and
icotine on number of biochemical variables indicative of oxidative
tress. Further we also studied if there is any synergism between
rsenic and nicotine during co-exposure which would alleviate
hanges upon tobacco smoking in arsenicosis areas.
. Material and method
.1. Chemicals
Sodium meta arsenite was obtained from E. Merck (Darmstadt,
ermany), nicotine as nicotine hydrogen tartarate was  procured
rom Sigma–Aldrich (St. Louis, MO,  USA), while all other chemicals
ere of “AnalaR” or “Extra pure” grade and obtained from BDH
hemicals (Mumbai, India), Merck (Darmstadt, Germany) or Sigma
St. Louis, MO,  USA).
.2. Experimental design
Forty-eight male Wistar rats (60–80 g, ∼5 weeks) were obtained
rom the animal facility of Defence Research and Development
stablishment (DRDE). They were maintained on ad libitum pellet
iet (Lipton’s India Ltd) and water in an air-conditioned room with
egular alternate cycles of 12 h light and darkness. The metal con-
ents of the animal feed (in ppm dry wt.) were Cu 10, Mn  55, Co 5, Zn
5, and Fe 70. The animals were weighed every week and the doses
ere adjusted accordingly. All animals received humane care in
ompliance with the guidelines of the “Committee for the Purpose
f Control and Supervision of Experiments on Animals (CPCSEA)”.
he animals were acclimatized for 7 days prior to their use in exper-
ments and were allowed a standard diet and water throughout the
tudy. All 48 animals were randomized into 4 groups of 12 rats each
nd were treated as below for 5 months-
Group 1: Control (treated as normal and received normal water)
Group 2: Arsenic as sodium meta-arsenite (25 ppm in drinking
ater)
Group 3: Nicotine as nicotine dihydrogen tartarate (0.25 mg/kg
ody weight subcutaneously)
Group 4: Arsenic + Nicotine (same as in group 2 and 3, respec-
ively)
After 5 months, rats were anesthetized under light ether and
he blood samples were collected using a needle via intra-cardiac
uncture to evaluate blood and serum biochemical variables after
5 days, 1 month and thereafter every month till the date of sacri-
ce. After 5 months, exposure was stopped and blood was collected
n heparinized vials and serum was collected in non-heparinized
ubes for biochemical estimation. Animals were quickly dissected
nder light ether anaesthesia, 24 h after the last dosing. Brain, liver
nd kidney was removed, washed thoroughly with chilled normal
aline and stored at −80 ◦C until use for biochemical estimation.
iver and brain tissue required for gene expression analysis are
ashed with ice cold DEPC (diethyl pyrocarbonate)—treated water
o remove extraneous material and kept at −20 ◦C in RNAlater®.
.3. Biochemical assays
Amount of ROS in blood and tissues was  measured using
′,7′-dichlroﬂuorescin diacetate (DCF-DA) as described by Socci
t al. [59]. Analysis of blood GSH concentration was  performed by
ethod of Ellman et al. [8] slightly modiﬁed by Jollow et al. [26].
educed glutathione (GSH) and oxidized glutathione (GSSG) con-
ent in tissue samples were measured as described by Hissin and
ilf [18]. SOD activity was assayed by the method of Kakkar et al.ts 2 (2015) 1334–1346 1335
[27]. Catalase activity in tissue was assayed following the procedure
of Sinha et al. [57]. Measurement of lipid peroxidation was done by
the method described by Ohkawa et al. [46]. Glutathione peroxidase
was determined by the literature method [10]. GST activity was
determined by Habig et al. [16]. Glutathione reductase was deter-
mined by the literature method of Worthington and Rosemeyer
[68]. Glutamic oxaloacetic transaminase (GOT), Glutamic pyruvic
transaminase (GPT), Urea, Creatinin and Lactate dehydrogenase
(LDH) activities were measured in serum using Merck kits. 8-OHdG
concentration in the urine was  estimated using highly sensitive
ELISA kit. Arsenic was  estimated using a Hydride Vapor Generation
System (PerkinElmer model MHS-10) ﬁtted with an atomic absorp-
tion spectrophotometer (AAS, PerkinElmer model AAnalyst 100) by
Parker et al. [49].
2.4. RNA isolation and RT-PCR
RNA stabilized whole brain was minced and 35 mg liver, 50 mg
kidney and 75 mg  of minced brain was used for RNA isolation.
Total RNA was  isolated from brain, liver and kidney as previous
reported [39]. All RNA samples were stored at −80 ◦C for further
experiments.
Two  micrograms of RNA was  converted to cDNA using the
First strand synthesis kit as described previously [38]. For semi-
quantitative RT-PCR, 5 ng cDNA template was  used for each sample
and PCR was performed for 30 cycles 95 ◦C for 15 s, varying
annealing temperature for 30 s and 72 ◦C for 30 s, with initial deac-
tivation at 95 ◦C for 5 min  and ﬁnal extension at 72 ◦C for 7 min
in GeneAmp PCR system 2700 (Applied Biosystems, USA). PCR
products were electrophoresed on 1.5% agarose gel with ethidium
bromide (Sigma–Alrich, MO,  USA) and bands were visualized and
recorded using Geldoc XR (Bio-Rad, Hercules, California, USA). List
of primers used in the study are described in Table 1.
2.5. Statistical analysis
Experimental results were expressed as the mean ± SEM and
were accompanied by number of observations. Data was assessed
by the method of one-way analysis of variance (ANOVA) followed
by Bonferroni test. Values with different symbols were signiﬁcantly
different from one another at the 5% level of probability.
3. Results
3.1. Effect on body weight index
Gain in body weight was  recorded every week and the change
in body weight (after completion of exposure—before exposure
started) was presented in Fig. 1. There was  signiﬁcant decrease in
the body weight gain in all the exposed groups as compared to
normal animals.
3.2. Effect on blood oxidative stress variable
Individual arsenic and nicotine exposure in animals demon-
strated consistent time dependent increase in blood reactive
oxygen species (ROS) levels. However, in the combined exposure
group, this increase was  only observed up to 3 months with no
further increase (Fig. 2). Interestingly, an increase after 15 days fol-
lowed by subsequent decline up to 3 months in GSH was noted in
all the exposed groups. After 3 months an elevated level of GSH
was found in all exposed group. Blood TBARS levels increased at
various stages of the study following various exposures, however,
there was  no particular trend observed (Fig. 2).
Co-exposure of As and nicotine demonstrated a signiﬁcant
increase in GPx activity by 1 month that continued till 3 months,
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Table 1
List of primers used in the study.
Genes Primer sequence (5′ to 3′) Ta Product size
-actin F’-GAGAGGGAAATCGTGCGTGACR’-CATCTGCTGGAAGGTGGACA 65 ◦C 453 bp
Catalase F’-TGGCCTCCGAGATCTTTTCAATGR’-GCGCTGAAGCTGTTGGGGTAGTA 63 ◦C 452 bp
GPx  F’-CGCTCATGACCGACCCCAAGTR’-GCCAGCCATCACCAAGCCAATA 65 ◦C 221 bp
GST  F-5′-CTAGTAAGTTCGCGCCGCCCAG-3′R- 5′-AGGGAGCAGAGCCTTGCAACC-3′ 65 ◦C 350 bp
Cu  Zn SOD F’-GCGGCTTCTCTCGTCTCCTTGCR’- TTGATGGACATGGAACCCATGCTCG 65 ◦C 201 bp
Mn  SOD F’-ACAGCAAGCACCACGCGACCR’- AACACCCACCACGGGCCTGA 67 ◦C 560 bp
Bax  F-5′-GGATGGCTGGGGAGACACCTGAG -3′R-5-CGGCCCCAGTTGAAGTTGCCATCAG-3′ 65 ◦C 217 bp
Bcl2 F-5′-TGAGAGCAACCGAACGCCCG-3′R-5′-GCACCCAGAGTGATGCAGGCC-3′ 65 ◦C 534 bp
Caspase 3 F-5′-GCAGAGCCATGGGCACGTCTT-3′R-5′-TGGGCTGCAGGGCCTATTGC-3′ 63 ◦C 315 bp
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Fig. 1. Effect of arsenic and nicotine on body weight index in exposed rats after 6 months.
Units: gain in body weight is expressed as grams (gms)
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p < 0.05 Compared to normal animals.
owever, in individual treatment increased GPx activity was  only
oted by 3 months. However, GR activity demonstrated a signiﬁ-
ant increase in 1 month followed by a signiﬁcant decrease in its
ctivity. This increase at 1 month was mainly contributed by arsenic
nd not nicotine (Fig. 3). Unlike GPx and GR, GST levels remained
igniﬁcantly elevated throughout the study in individual as well as
o-exposure groups (Fig. 3).
.3. Effect on serum biochemical variables indicative of liver,
idney and membrane damage (Figs. 4 and 5)
There was a signiﬁcant increase in SGOT, SGPT activity in all
reated groups as compared to controls. However, the levels ﬂuc-
uated over various time points but were highest at 5 months in all
reated groups. Unlike SGOPT and SGPT, LDH levels increased in a
ime dependent manner where the highest levels were reached by
 months of exposure. Co-exposure of arsenic and nicotine showed
ore damage as compared to the individual treatments (Fig. 4).
rsenic, nicotine and co-exposed animals all showed an elevated
rea level during the entire experimental period (Fig. 5). However,
here was no time dependent trend observed. Likewise creatinine
oo showed an increased response following various treatments
ver the study period (Fig. 5).
.4. Effect on 8-OHdG concentration in urine (Fig. 6)There was an equal increase in urine 8-OHdG concentration
pon arsenic or nicotine exposure. In the combination group, an
levated concentration of 8-OHdG was observed as compared tocontrols however, these levels were lower than the individual treat-
ment groups .
3.5. Effect on brain biochemical variables (Table 2)
In brain, arsenic exposure led to a signiﬁcant increase in ROS
level and a decrease in enzymes regulating GSH and maintaining
ROS balance, except GR suggesting oxidative stress. Interestingly,
nicotine only affected GSH regulating enzymes (GPx and GR) more
pronouncedly as compared to control animals during the exposure
period. Co-exposure to arsenic + nicotine led to a more pronounced
increase ROS and GSSG while to our surprise there was an increase
in GSH level (Table 2).
3.6. Effect on hepatic biochemical variables (Table 3)
Most of the hepatic oxidative stress variables demonstrated
marked alteration following treatment of arsenic and nicotine
alone or in combination. However, there were subtle differences
between the treated groups. While arsenic exposure alone did
not signiﬁcantly affect the levels of catalase, GR and GST, nico-
tine exposure alone depleted catalase and GR  and increased
GST levels (Table 3), suggesting differential effects of com-
pounds.
3.7. Effect on renal biochemical variables (Table 4)Renal oxidative stress variables indicated similar alterations
in oxidative stress variables in all the exposed groups with an
increase in ROS and TBARS on arsenic and nicotine exposure. On
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Fig. 2. Effect of co-exposure of arsenic and nicotine on ROS, GSH and TBARS concentration in blood.
Abbreviations and units: Reactive Oxygen Species (ROS) as M ml−1 blood; Reduced Glutathione (GSH) as mg/ml blood and TBARS—nmoles MDA produced/ml blood.
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p < 0.05 Compared to normal animals.
he other hand there was a signiﬁcant depletion in the level of
SH, GSH/GSSG ratio, catalase, GPx and GST activities. Interestingly,
hese changes during individual exposure do not led to a synergistic
ffects as there was increase in ROS but it was almost the same as in
icotine exposed group while there was only a marginal synergistic
ffects in GSSG and GSH/GSSG ratio. The changes in TBARS, cata-
ase, GPx and GST were almost the same as observed with individual
xposure .3.8. Effect on arsenic concentration in blood and tissues (Fig. 7)
As expected, signiﬁcant accumulation of arsenic was observed
in blood and all tissues studied following chronic exposure to
arsenic. However, co-exposure of arsenic and nicotine together
demonstrated a highly signiﬁcant arsenic accumulation in blood
and kidney and a marked reduction in liver concentration in com-
parison to only arsenic exposed groups, indicating the inﬂuence of
nicotine on the arsenic levels .
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Fig. 3. Effect of co-exposure of arsenic and nicotine on GPx, GR and GST activity in blood.
Abbreviations and units: Glutathione Peroxidase as GPx-mM/ml blood; Glutathione Reductase as GR-mg/ml blood and Glutathione S-Transferase as GST—nM conju-
gate/min/mg protein.
Values are mean ± SE; n = 5.
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rp < 0.05 Compared to normal animals.
p  < 0.05 Compared to arsenic exposed group.
.9. Effect on liver and brain antioxidant mRNA expression in rats
Figs. 8–10)Brain catalase transcript level showed decreased expression but
t was not statistically signiﬁcant. Nicotine exposure on the other
esulted in signiﬁcant decrease in Cu-Zn SOD and GST transcriptlevels. No change in other mRNA expression of other antioxidants
was however noted in brain .
Liver catalase, Cu-Zn SOD and MnSOD mRNA expression levels
were down-regulated in co-exposed group compared to normal
group. Arsenic exposure however led a down regulation of GPx
transcript while no change in other groups were noted.
A. Jain et al. / Toxicology Reports 2 (2015) 1334–1346 1339
Fig. 4. Effect of co-exposure of arsenic and nicotine on GOT, GPT and LDH activity in serum.
Abbreviations and units: Serum Glutamic oxaloacetic transaminase (GOT) as U/l; Serum Glutamic pyruvic transaminase (GPT) as U/l and Lactate dehydrogenase (LDH) as U/l.
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calues  are mean ± SE; n = 5.
p < 0.05 Compared to normal animals.
 p < 0.05 Compared to arsenic exposed group.
.10. Effect on liver and brain apoptotic gene mRNA expression in
ats (Fig. 11)There was an increase in hepatic Bax transcript level in all
f the exposed groups but was more prominent in nicotine and
o-exposed group as compared to controls. Hepatic Bcl2 (anti-apoptotic protein) and Caspase 3 mRNA expression also showed
a slight down regulation in co-exposed group .An increase in brain Bax expression in arsenic and
co-exposed group along with an increased caspase
3 expression in co-exposed group was also observed. In con-
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Fig. 5. Effect of co-exposure of arsenic and nicotine on urea and creatinine level in serum.
Abbreviations and units: serum urea as mg/dl and Creatinine as mg/dl.
Values are mean ± SE; n = 5.
*p < 0.05 Compared to normal animals.
†  p < 0.05 Compared to arsenic exposed group.
Table 2
Effect of co-exposure of arsenic and nicotine on brain oxidative stress variables in
rats.
Normal Arsenic Nicotine As + Nicotine
ROS 272.7 ± 1.7 285.4 ± 0.7* 293.6 ± 5.9* 308.3 ± 0.4*, **
GSH 5.48 ± 0.08 4.65 ± 0.11* 5.31 ± 0.14 6.16 ± 0.20*, **
GSSG 2.13 ± 0.03 1.92 ± 0.14 2.64 ± 0.09 2.81 ± 0.20*, **
GSH/GSSG 2.59 ± 0.03 2.20 ± 0.08* 2.09 ± 0.09* 2.07 ± 0.11*
TBARS 2.43 ± 0.09 2.83 ± 0.24 2.87 ± 0.18 3.04 ± 0.13
SOD  2.09 ± 0.23 1.42 ± 0.09* 1.28 ± 0.14* 0.876 ± 0.08*
Catalase 4.19 ± 0.14 3.16 ± 0.34* 3.00 ± 0.10* 3.05 ± 0.13*
GPx 0.501 ± 0.007 0.405 ± 0.031* 0.417 ± 0.014* 0.429 ± 0.008
GR 8.10 ± 0.33 7.68 ± 0.16 7.20 ± 0.25* 8.49 ± 0.06
GST  4.70 ± 0.06 4.15 ± 0.11* 4.63 ± 0.10 4.35 ± 0.05*
Abbreviations and units: Reactive Oxygen Species as ROS—FIU; Reduced glutathione
as  GSH—mg/gm, Oxidized glutathione as GSSG—mg/gm, Thiobarbituric acid reac-
tive substances as TBARS——g/gm, Superoxide dismutase as SOD—units/min/mg
protein; Catalase—moles H2O2 produced/min./mg protein; Glutathione Peroxi-
dase as GPx—nmole conjugate produced/min/mg protein; Glutathione reductase
as GR—units/l and Glutathione S-transferase as GST—mole/min/mg protein.
Values are mean ± SE; n = 5.
* p < 0.05 Compared to normal control group.
** p < 0.05 Compared to normal arsenic group.
Table 3
Effect of co-exposure of arsenic and nicotine on liver oxidative stress variables in
rats.
Normal Arsenic Nicotine As + Nicotine
ROS 713.1 ± 10.3 821.4 ± 21.7* 948.3 ± 9.6* 852.8 ± 10.5*
GSH 11.1 ± 0.33 8.23 ± 0.31* 12.0 ± 0.26 10.3 ± 0.38**
GSSG 3.72 ± 0.07 2.76 ± 0.10* 3.62 ± 0.15 3.06 ± 0.15*
GSH/GSSG 3.24 ± 0.07 2.74 ± 0.07* 2.94 ± 0.06* 3.13 ± 0.05**
TBARS 4.71 ± 0.06 6.17 ± 0.17* 8.92 ± 0.17* 7.12 ± 0.38*, **
SOD 3.95 ± 0.08 3.22 ± 0.14* 3.14 ± 0.19* 3.15 ± 0.21*
Catalase 6.75 ± 0.33 6.30 ± 0.21 4.34 ± 0.27* 4.11 ± 0.22*
GPx 0.513 ± 0.018 0.380 ± 0.016* 0.297 ± 0.015* 0.336 ± 0.009*
GR 38.9 ± 0.14 38.2 ± 1.17 33.1 ± 1.03* 36.1 ± 0.2
GST 11.1 ± 0.1 12.6 ± 0.3 14.6 ± 1.0* 10.3 ± 0.9
Abbreviations and units: Reactive Oxygen Species (ROS)—FIU; Reduced glu-
tathione (GSH)—mg/gm, Oxidized glutathione (GSSG)—mg/gm, TBARS—g/gm,
Superoxide dismutase (SOD)—units/min./mg protein; Catalase—moles H2O2
produced/min/mg protein; Glutathione Peroxidase as GPx—nmole conjugate pro-
duced/min/mg protein; Glutathione reductase as GR—units/l and Glutathione
S-transferase as GST—mole/min/mg protein.
Values are mean ± SE; n = 5.
*p < 0.05 When all the exposed groups (arsenic, nicotine and arsenic + nicotine) were
compared with normal animals.
**p < 0.05 When co-exposed group was compared to arsenic group.
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Fig. 6. Effect of co-exposure of arsenic and nicotine on 8-OHdG concentration in urine as an indicator of DNA damage.
Abbreviations and units: 8-oxo 2′ deoxy Guanosine is expressed as 8-OHdG.
Values are mean ± SE; n = 5.
*p < 0.05 Compared to normal animals.
†  p < 0.05 Compared to arsenic exposed group.
Fig. 7. Effect of co-exposure of arsenic and nicotine on arsenic concentration in blood, brain, liver and kidney.
Units:  arsenic in blood is expressed as g/ml blood, arsenic in brain, liver and kidney are expressed as g g−1 tissue weight.
Values are mean ± SE; n = 5.
*p < 0.05 Compared to normal animals.
†  p < 0.05 Compared to arsenic exposed group.
Fig. 8. Total RNA isolation from (A) liver and (B) brain of control and exposed animals after 6 months of exposure. Lane 1—Group 1 (Normal) Lane 2—Group 2 (Arsenic) Lane
3—Group 3 (Nicotine) Lane 4—Group 4 (Nicotine + As).
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s  compared with control after 6 months of exposure. Lane 1—Group 1 (Normal) La
p  < 0.05 Compared to normal animals.
rary a decreased Bcl2 mRNA transcript level was found in both the
ndividually exposed arsenic and nicotine groups.
. Discussion
Arsenic and nicotine are known to induce oxidative stress.
rsenic induces oxidative stress via generation of reactive oxygen
pecies, reactive nitrogen species and also other reactive metabo-
ites of arsenic such as dimethyl arsenic peroxyl radicals, dimethyl
rsenic radicals etc [12]. Enhanced generation of reactive oxygen
nd nitrogen species is associated with a deﬁcient antioxidant sys-
em leading to increased oxidative stress and is largely accepted
s one of the common mechanisms of arsenic-induced neurotoxi-
ity [48,11,56,58,6]. Arsenic is also known to induce carcinogenic
ffects in skin, lungs, liver, kidneys and bladder [66]. On the other
and, nicotine toxicity depends largely on the dose and duration
f exposure. Exposure to a low dose and for a shorter durationD (560 bp), GPx (221 bp) and GST (350 bp) in arsenic and nicotine exposed rat liver
Group 2 (Arsenic) Lane 3—Group 3 (Nicotine) Lane 4—Group 4 (Nicotine + As).
exhibits antioxidant properties [41] while, prolonged exposure to
a higher dose generates free radicals resulting in oxidative stress
and reduction in antioxidant enzymes [15]. Interestingly, not only
these compounds generated free radicals during their metabolism
but also altered the gene expression levels of anti-oxidant enzymes
[52,1,3,69]
Arsenic and nicotine individually and in combination demon-
strated signiﬁcant decrease in body weight which could be due to
(i) increased metabolic rate [13], (ii) activation of lipoprotein lipase
[67] or (iii) suppression of glycolysis [37]. We  observed a signiﬁcant
increase in ROS in the exposed groups, however, animals co-
exposed to arsenic and nicotine demonstrated comparatively less
pronounced increase in ROS compared to the individual exposures,
suggesting that effects on ROS were not cumulative but demon-
strate largely antagonistic effects which may  thus be attributed
to a mechanism which currently is unknown and require further
investigation.
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Arsenic induced changes in glutathione have been reported pre-
iously [24,12]. All the exposed groups showed an initial increase in
SH concentration but gradually it started showing a decrease com-
ared to normal animals. After three months of exposure GSH level
gain showed a marked increase suggesting an adaptive mecha-
ism might have been developed. An increase in lipid peroxidation
as observed in all the exposed groups and the changes were con-
istent throughout the duration of exposure [51,62]. Glutathione
eroxidase and glutathione reductase activities showed a similar
rends after month 1 and 3 in all exposed groups compared to nor-
al  animals. A moderate synergism however was noted in GPx
ctivity after combined exposure to arsenic and nicotine. There was
asking of nicotine effects by arsenic in the combination group in
lood GR activity. An increase in GST activity in all the exposednSOD (560 bp), GPx (221 bp) and GST (350 bp) in arsenic and nicotine exposed rat
e 2—Group 2 (Arsenic) Lane 3—Group 3 (Nicotine) Lane 4—Group 4 (Nicotine + As).
groups may  be attributed to the involvement of GST in arsenic and
nicotine detoxiﬁcation [25,65].
Elevated serum transaminases activities suggested hepatic
injury. Elevated serum GOT activity was noted in all the exposed
groups throughout the exposure period (from day 15 to 6 month)
indicating liver injury. Interestingly, serum GPT activity decreased
in animals co-exposed to nicotine and arsenic compared to nor-
mal, arsenic or nicotine group after day 15 and 2 month suggesting
antagonism which needs to be explored further. Increased serum
urea and creatinine levels indicated renal damage. Previous studies
have reported arsenic or nicotine induced hepatic injury and renal
dysfunction on continuous exposure [61,23,35,65,55]. Serum urea
increased in all the exposed groups throughout the exposure period
except in the ﬁrst month when we noted a moderate decrease in
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ontrol after 6months of exposure. Lane 1—Group 1 (Normal) Lane 2—Group 2 (Ars
p  < 0.05 compared to normal animals.
he combination group. A similar trend in the serum creatinin level
as also noted. Lactate dehydrogenase activity in the serum is con-
idered as marker of membrane damage, and it was  found elevated
n arsenic or nicotine exposure [32,42]. We  noted no changes in
DH activity after day 15 and 3 months in any of the exposed groups
tudied. However, a similar trend was observed after month 1, 5 and
. During this period there was a prominent increase in the serum
DH activity in the combination group as compared to individual
xposed group.
8-oxo 2′deoxy Guanosine (8-OHdG) concentration was evalu-
ted in the urine as an indicator of oxidative DNA damage. An
ncreased concentration of 8-OHdG in the urine suggest DNA dam-
ge. No difference however was noted between the exposed group.
-OHdG has been reported to be marker for age related chronic
iseases [50,31].-3 (315 bp) in arsenic and nicotine exposed rat liver and brain as compared with
ane 3—Group 3 (Nicotine) Lane 4-Group 4 (Nicotine + As).
Brain biochemical variables suggested an increased oxidative
stress in animals co-exposed to arsenic and nicotine compared to
normal animals. Arsenic or nicotine induced increased brain reac-
tive oxygen species and a decreased antioxidant level has been
reported earlier [48,20]. We  report no signiﬁcant difference in the
toxicity among the two exposed groups except the brain SOD activ-
ity exhibited a more pronounced depletion in co-exposed group
compared to normal and individual exposed group. These ﬁndings
are in consistent with the brain arsenic concentration which was
same as in arsenic alone group. Semi quantitative gene expression
analysis in the present study of certain antioxidant enzymes also
indicated a decrease in the level of antioxidant mRNA transcript
level in the exposed groups but the reason behind changes in the
expression is not clear
A. Jain et al. / Toxicology Repor
Table  4
Effect of co-exposure of arsenic and nicotine on renal oxidative stress variables in
rats.
Normal Arsenic Nicotine As+ Nicotine
ROS 479.2 ± 5.3 492.8 ± 3.3* 565.5 ± 28.5* 543.4 ± 17.3*
GSH 8.45 ± 0.35 6.68 ± 0.49* 7.91 ± 0.24* 8.79 ± 0.32**
GSSG 2.57 ± 0.08 2.39 ± 0.07 2.51 ± 0.05 2.95 ± 0.14*, **
GSH/GSSG 3.43 ± 0.12 2.65 ± 0.17* 2.87 ± 0.16* 3.22 ± 0.03**
TBARS 2.29 ± 0.02 3.04 ± 0.28* 3.10 ± 0.15* 3.15 ± 0.09*
SOD 2.53 ± 0.06 2.11 ± 0.11 1.92 ± 0.15* 1.95 ± 0.06*
Catalase 4.88 ± 0.62 3.49 ± 0.30* 3.25 ± 0.39* 2.89 ± 0.12*
GPx 0.487 ± 0.02 0.371 ± 0.03* 0.37 ± 0.02* 0.372 ± 0.02*
GR 38.1 ± 1.8 34.7 ± 1.3 31.7 ± 1.5 35.7 ± 1.1
GST  9.8 ± 0.8 4.71 ± 0.3* 6.60 ± 0.3* 6.32 ± 0.4*
Abbreviations and units: Reactive Oxygen Species (ROS)—FIU; Reduced glu-
tathione (GSH)—mg/gm, Oxidized glutathione (GSSG)—mg/gm, TBARS—g/gm,
Superoxide dismutase (SOD)—units/min/mg protein; Catalase—moles H2O2
produced/min/mg protein; Glutathione Peroxidase as GPx—nmole conjugate pro-
duced/min/mg protein; Glutathione reductase as GR—units/l and Glutathione
S-transferase as GST—mole/min/mg protein.
Values are mean ± SE; n = 5.
*p < 0.05 When all the exposed groups (arsenic, nicotine and arsenic + nicotine) were
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Nicotine administration reduces neuropeptide Y and neuropeptide Y mRNAompared with normal animals.
*p < 0.05 When co-exposed group was compared to arsenic group.
The extend of oxidative injury in brain of arsenic exposed
nimals was comparatively less pronounced compared to nico-
ine exposed group. Arsenic and nicotine induced hepatic injury
articularly oxidative stress has been extensively studied [12,7]
uggesting that both arsenic and nicotine induced oxidative stress
argets liver. It was thus expected that the level of toxicity would
e higher in combination group compared to individual exposure
roups.
However, it was not seen in the present study possibly due to
ecreased uptake of arsenic in the co-exposed groups. Decreased
iver arsenic level in co-exposed group is possibly due to nicotine
nduced altered arsenic metabolism. It has been reported earlier
hat all forms of tobacco use is associated with less efﬁcient arsenic
ethylation as the smoking inhibits the speciﬁc AS3MT involved
n arsenic methylation [33]. Cigarette smoking is also known to
ncrease serum homocysteine concentration [45,53], which, via
he concurrent accumulation of S-adenosylhomocysteine, exerts
 strong inhibition of S-adenosylmethionine-dependent trans-
ethylation reactions, including those of arsenic [14,36]. Smokers
lso tend to have lower levels of folate and vitamin B6 and B12 [45],
hich are essential for homocysteine metabolism and thus increas-
ng its accumulation. Altogether, these alterations to decreased
iver arsenic concentration in co-exposed group and thus less pro-
ounced oxidative stress than expected. Liver antioxidant mRNA
xpression was also studied and the down regulation of certain
ntioxidant mRNA transcript was observed in arsenic and co-
xposed group but the exact mechanism behind these alterations
eed to be understood. All of these changes ultimately resulted in
ecreased protein expression in liver of exposed groups.
Arsenic or nicotine exposure leads to renal oxidative stress dur-
ng its metabolism suggesting nephrotoxicity [2,54]. In the present
tudy, all the exposed groups showed renal injury in terms of
ncreased oxidative stress. Increased kidney arsenic concentration
n co-exposed group was also possibly due to nicotine induced
ltered arsenic metabolism in liver leading to enhanced elimination
y kidney.
Arsenic or nicotine stimulated apoptosis was investigated in
arlier studies and it was observed that both toxicants are respon-
ible for apoptosis related cell death [40,71]. An increased liver
ax (apoptotic protein) mRNA expression in the nicotine alone and
ombination group compared to normal group suggest suscepti-
ility to apoptosis in arsenic exposed group. On the other hand
n the co-exposed group a slight decreased caspase 3 expression
[ts 2 (2015) 1334–1346 1345
was found. A more detailed study is thus required to unequiv-
ocally establish the effects of combined exposure on apoptotic
pathway. We  observed an increased brain Bax level in arsenic and
arsenic + nicotine co-exposed animals while, increased caspase 3
was noted in arsenic + nicotine co-exposed rat brain suggesting
an increased apoptosis. However, we  admit that apoptotic gene
expression data did not provide a ﬁnal conclusion.
To our knowledge this is the ﬁrst study to suggest possible syner-
gism between arsenic and nicotine co-exposed animals. However,
this was established based only on few variables. Thus there is need
to have a more detailed study to establish mechanism that nico-
tine is a major factor behind synergism earlier reported between
tobacco and arsenic. We  further suggest a possibility that other
than nicotine there might possibly be other constituent(s) moi-
eties responsible for the reported synergism. There was  a signiﬁcant
alteration in antioxidant gene expression levels but the mecha-
nisms behind these changes are not known. It can thus be concluded
that both arsenic and nicotine if given individually or in combi-
nation are toxic at the present dose and duration. Further studies
need to be done in this direction to study the exact mechanism
behind synergism between arsenic and nicotine on oxidative stress
or apoptosis.
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